Article

Ketamine as an adjunctive therapy for major depression - a randomised controlled pragmatic pilot trial (Karma-Dep Trial)

2022-01-27

Abstract excerpt

<h4>Background: </h4> Depression is a common psychiatric disorder that has become the leading cause of disability worldwide. The standard medical care for depression over the past 50 years has focused on monoamine neurotransmitters. These treatments can take weeks to take effect, highlighting the need for novel treatment strategies. One such approach may be ketamine. Ketamine acts as an antagonist of the N-methyl-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7e400146-f790-5cc2-9426-d8fc576d0d89
DOI: 10.12688/hrbopenres.13182.2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Ketamine as an adjunctive therapy for major depression - a randomised controlled pragmatic pilot trial (Karma-Dep Trial)DOI 10.12688/hrbopenres.13182.2Read

Ketamine in severe, highly treatment-resistant depression—a retrospective case study and a perspectiveSemantic proximity Read

Real-world patient characteristics, treatment patterns, efficacy and safety of intramuscular ketamine treatment: a retrospective cohort studySemantic proximity Read

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extensionSemantic proximity Read

Propofol for treatment resistant depression: A randomized controlled trialSemantic proximity Read

Protocol Development for a Qualitative Methodological Study Within a Trial (Qual-SWAT): The KARMA-Dep-2 TrialSemantic proximity Read

Opioids Diminish the Placebo Antidepressant Response: A Post Hoc Analysis of a Randomized Controlled Ketamine TrialSemantic proximity Read

Sublingual Ketamine for Depression and Anxiety: A Retrospective Study of Real-World Clinical OutcomesSemantic proximity Read

Ketamine Reimagined: Distinguishing Psychedelic and Psycholytic Modalities for Next-Generation Therapies.Semantic proximity Read

Combined Ketamine and Psychotherapy Provide No Additional Benefit Beyond Ketamine Alone in Treating Depression or PTSD: Evidence from a Help-Seeking SampleSemantic proximity Read

Ketamine-assisted psychotherapy provides lasting and effective results in the treatment of depression, anxiety and post traumatic stress disorder at 3 and 6 months: Findings from a large single-arm retrospective effectiveness trialSemantic proximity Read

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Trial to Verify the Efficacy and Safety of Ansofaxine (LY03005) for Major Depressive DisorderSemantic proximity Read

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.Semantic proximity Read